NBDF showcases a wide array of findings from the latest in bleeding disorders research at our annual Bleeding Disorders Conference.

Surgical Experience in Two Multicenter, Open-label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

Surgical Experience in Two Multicenter, Open-label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2)

AWARDED/PRESENTED: 2018
GRANT/PROGRAM:
Bleeding Disorders Conference
Clinical Research/Clinical Trials
RESEARCHERS:
Tiffany Chang, Christophe Dhalluin, Guy Young, Johannes Oldenburg, Richard Ko, Liane Khoo, Michael Callaghan, Paul Solari, Rebecca Kruse-Jarres, Michael Recht, Ri Liesner, Stacy Croteau, Tadashi Matsushita, Benjamin Trzaskoma, Victor Yuste, Jin Xu
Giving men with vwd a voice

Giving men with vwd a voice

AWARDED/PRESENTED: 2018
GRANT/PROGRAM:
Bleeding Disorders Conference
Peer Support/Outreach/Integration Models
RESEARCHERS:
Felix Olaya, Kate Nammacher
Discrepant Hemophilia A: Single Institution Experience

Discrepant Hemophilia A: Single Institution Experience

AWARDED/PRESENTED: 2018
GRANT/PROGRAM:
Bleeding Disorders Conference
Clinical Research/Clinical Trials
RESEARCHERS:
Ahmad Alhuniti, Anjali Sharathkumar, Karla Watkinson, Michelle Krantz, Sharathkumar Bhagavathi, Usha Perepu